(Q42515923)

1 November 2017

title

Silencing of the transcription factor STAT3 sensitizes lung cancer cells to DNA damaging drugs, but not to TNFα- and NK cytotoxicity (English)

1 reference

1 November 2017

0 references

3

Salem Chouaib

1 reference

1 November 2017

Dorota W Kulesza

1

1 reference

1 November 2017

Thibault Carré

series ordinal

2

1 reference

1 November 2017

Bozena Kaminska

series ordinal

4

1 reference

1 November 2017

language of work or name

English

0 references

publication date

10 November 2012

1 reference

Experimental Cell Research

1 November 2017

published in

1 reference

1 November 2017

volume

319

1 reference

1 November 2017

issue

4

1 reference

1 November 2017

page(s)

506-516

1 reference

Mechanisms of disease: Insights into the emerging role of signal transducers and activators of transcription in cancer

1 November 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2012.11.005

Constitutive activation of Stat3 signaling confers resistance to apoptosis in human U266 myeloma cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2012.11.005

Stat proteins and oncogenesis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2012.11.005

Inhibition of pp60c-Src reduces Bcl-XL expression and reverses the transformed phenotype of cells overexpressing EGF and HER-2 receptors

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2012.11.005

Signal transducer and activator of transcription-3, inflammation, and cancer: how intimate is the relationship?.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2012.11.005

Interleukin-11 up-regulates survivin expression in endothelial cells through a signal transducer and activator of transcription-3 pathway

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2012.11.005

JAK2/STAT3 signaling pathway activation mediates tumor angiogenesis by upregulation of VEGF and bFGF in non-small-cell lung cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2012.11.005

Regulation of the innate and adaptive immune responses by Stat-3 signaling in tumor cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2012.11.005

Crosstalk between cancer and immune cells: role of STAT3 in the tumour microenvironment.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2012.11.005

Down-regulation of signal transducer and activator of transcription 3 expression using vector-based small interfering RNAs suppresses growth of human prostate tumor in vivo

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2012.11.005

Down-regulation of STAT3 expression by vector-based small interfering RNA inhibits pancreatic cancer growth

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2012.11.005

Targeted inhibition of Stat3 with a decoy oligonucleotide abrogates head and neck cancer cell growth

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2012.11.005

Silencing of signal transducer and activator of transcription 3 expression by RNA interference suppresses growth of human hepatocellular carcinoma in tumor-bearing nude mice

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2012.11.005

Targeting the STAT pathway in head and neck cancer: recent advances and future prospects.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2012.11.005

Targeting STAT3 in cancer: how successful are we?

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2012.11.005

Therapeutic effects of STAT3 decoy oligodeoxynucleotide on human lung cancer in xenograft mice

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2012.11.005

Inhibition of STAT-3 results in greater cetuximab sensitivity in head and neck squamous cell carcinoma

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2012.11.005

Activated epidermal growth factor receptor-Stat-3 signaling promotes tumor survival in vivo in non-small cell lung cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2012.11.005

Clinical impact of phosphorylated signal transducer and activator of transcription 3, epidermal growth factor receptor, p53, and vascular endothelial growth factor receptor 1 expression in resected adenocarcinoma of lung by using tissue microarray.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2012.11.005

Tumor resistance to specific lysis: a major hurdle for successful immunotherapy of cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2012.11.005

The cooperative induction of hypoxia-inducible factor-1 alpha and STAT3 during hypoxia induced an impairment of tumor susceptibility to CTL-mediated cell lysis.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2012.11.005

Cannabinoids down-regulate PI3K/Akt and Erk signalling pathways and activate proapoptotic function of Bad protein.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2012.11.005

Combined disruption of both the MEK/ERK and the IL-6R/STAT3 pathways is required to induce apoptosis of multiple myeloma cells in the presence of bone marrow stromal cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2012.11.005

Role of Stat3 in regulating p53 expression and function

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2012.11.005

Overview of cell death signaling pathways

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2012.11.005

NF-κB addiction and its role in cancer: 'one size does not fit all'.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2012.11.005

The role of STATs in transcriptional control and their impact on cellular function

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2012.11.005

Stat3 orchestrates tumor development and progression: the Achilles' heel of head and neck cancers?

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2012.11.005

Signal transducer and activator of transcription 1 (Stat1) maintains basal mRNA expression of pro-survival stat3-target genes in glioma C6 cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2012.11.005

Nuclear factor-kappaB inhibitors as sensitizers to anticancer drugs

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2012.11.005

Berberine modifies cysteine 179 of IkappaBalpha kinase, suppresses nuclear factor-kappaB-regulated antiapoptotic gene products, and potentiates apoptosis.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2012.11.005

STAT3 deletion during hematopoiesis causes Crohn's disease-like pathogenesis and lethality: a critical role of STAT3 in innate immunity

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2012.11.005

Persistently activated Stat3 maintains constitutive NF-kappaB activity in tumors

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2012.11.005

NF-kappaB/STAT3/PI3K signaling crosstalk in iMyc E mu B lymphoma

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2012.11.005

NF-κB and STAT3 signaling hubs for lung innate immunity

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2012.11.005

Combined targeting of epidermal growth factor receptor, signal transducer and activator of transcription-3, and Bcl-X(L) enhances antitumor effects in squamous cell carcinoma of the head and neck.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2012.11.005

Bcl-xL gene expression correlated with lower apoptotic cell numbers and shorter progression-free survival in PCFCL.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2012.11.005

Prognostic significance of bcl-xL gene expression and apoptotic cell counts in follicular lymphoma

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2012.11.005

Functional and biological analysis of Bcl-xL expression in human osteosarcoma

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2012.11.005

Estimation of prognostic value of Bcl-xL gene expression in non-small cell lung cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2012.11.005

siRNA-mediated Bcl-2 and Bcl-xl gene silencing sensitizes human hepatoblastoma cells to chemotherapeutic drugs

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2012.11.005

Bcl-XL small interfering RNA sensitizes cisplatin-resistant human lung adenocarcinoma cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2012.11.005

A small-molecule inhibitor of Bcl-XL potentiates the activity of cytotoxic drugs in vitro and in vivo

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2012.11.005

STAT3 knockdown by siRNA induces apoptosis in human cutaneous T-cell lymphoma line Hut78 via downregulation of Bcl-xL.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2012.11.005

10.1016/J.YEXCR.2012.11.005

7 January 2021

Identifiers

DOI

1 reference

1 November 2017

1 reference